effect of granisetron on preventing of shivering during and after spinal anesthesia for cesarean delivery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201008214583N2

Enrollment

Registered

2013-08-31

Start date

2013-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

shivering after spinal anesthesia. Disorders of other endocrine glands in diseases classified elsewhere

Interventions

Intervention 1: placebo. Intervention 2: Granisetron.

Treatment - Drugs

placebo

Granisetron

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: age 18_40 years old; undergoing spinal anesthesia for cesarean delivery. exclusion criteria: hyperthyroidism; cardiopulmonary diseases; history of drug abuse.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Shivering during and after spinal anesthesia. Timepoint: each 10 min during surgery until recovery. Method of measurement: by thermometer.	—

Secondary

Measure	Time frame
Core body temperature. Timepoint: each 10 min during surgery until recovery. Method of measurement: by thermometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactdr s. hossein moshtaghion

Shahid Sadoughi University of Medical Sciences

moshtaghion@ssu.ac.ir+98 35 1822 4000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026